RA tirzepatide for type 2 diabetes mellitus (T2DM) therapy has lower odds of instigating retinal complications.

In both studies, Vabysmo was found to be noninferior to aflibercept, with average vision gains being comparable between the treatment groups. The Food and Drug Administration (FDA) has approved ...

No overall change in retinal thickening with tonabersat but thicker retinas appeared to be ...

Credit: Shutterstock. Findings showed faricimab was associated with rapid drying of retinal fluid. The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application ...

The optic cup and macula of a 24-year-old female. Image is released to Wikimedia commons with patient consent. Imaged with a non-mydriatic fundus camera at Pacific University College of Optometry.

Adding vamikibart to VEGF inhibition improved visual acuity and retinal anatomy ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Better diabetes medications, better screening, older age at onset of DRD influence 20-year ...

Researchers also suggest potential new genetic associations with macular edema, which warrant further research. A study published in Scientific Reports confirmed previously identified retinal ...

New preclinical data presented demonstrate the candidates’ therapeutic potential as innovative treatments for retinal vascular diseases, such as DME and wAMD, providing potent and long-lasting ...